文献速递瓣膜外科

英国三瓣膜手术20年:人口学与结局趋势

20 Years of triple-valve surgery in the UK: demographic and outcome trends.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该研究回顾性分析2000–2019年英国国家登记数据中1750例三瓣膜手术患者,按每4年分为5组;住院死亡率由A组21%降至E组7%(P<0.001),平均年龄由63±12岁升至69±12岁(P<0.001),再手术胸骨切开是三瓣膜手术死亡的重要独立预测因素。

要点

  • 三瓣膜手术占数据集全部患者的3.1%,2000–2019年共1750例。
  • 住院死亡率从A组21%降至E组7%(P<0.001),总体为9%。
  • 再手术胸骨切开、三瓣膜置换和术前左心室射血分数差是死亡的强独立预测因素。

核心结论

  • 英国三瓣膜手术仍罕见,早期术后结局随时间改善,再手术胸骨切开是死亡的显著预测因素。
  • 原文建议在技术可行时尝试修复二尖瓣和/或三尖瓣。

研究设计与样本

  • 回顾性分析英国国家登记数据,纳入2000–2019年因各种病因行三瓣膜手术的患者,排除术前危重状态及入院日期缺失者。
  • 研究队列分为5个连续4年组(A、B、C、D、E组),共1750例,三瓣膜手术占数据集全部患者的3.1%。
  • 主要结局为住院死亡率,次要结局包括延长住院、因出血再探查、术后卒中和术后透析;采用二元逻辑回归确定死亡、卒中、术后透析和因出血再探查的独立预测因素。

主要发现

  • 总体平均年龄68.5±12岁,从A组63±12岁增至E组69±12岁(P<0.001)。
  • 总体住院死亡率9%,从A组21%降至E组7%(P<0.001)。
  • 因出血再探查总体发生率11%(P=0.308),术后透析总体发生率11%(P=0.066),在观察期间均保持较高水平。
  • 三瓣膜置换、再手术胸骨切开和术前左心室射血分数差是死亡的强独立预测因素。

临床怎么用

  • 原文指出再手术胸骨切开是死亡的显著预测因素。
  • 原文建议在技术可行时尝试修复二尖瓣和/或三尖瓣。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe evolving demographic trends and early outcomes in patients undergoing triple-valve surgery in the UK between 2000 and 2019. METHODS: We planned a retrospective analysis of national registry data including patients undergoing triple-valve surgery for all aetiologies of disease. We excluded patients in a critical preoperative state and those with missing admission dates. The study cohort was split into 5 consecutive 4-year cohorts (groups A, B, C, D and E). The primary outcome was in-hospital mortality, and secondary outcomes included prolonged admission, re-exploration for bleeding, postoperative stroke and postoperative dialysis. Binary logistic regression models were used to establish independent predictors of mortality, stroke, postoperative dialysis and re-exploration for bleeding in this high-risk cohort. RESULTS: We identified 1750 patients undergoing triple-valve surgery in the UK between 2000 and 2019. Triple valve surgery represents 3.1% of all patients in the dataset. Overall mean age of patients was 68.5 ± 12 years, having increased from 63 ±12 years in group A to 69 ± 12 years in group E (P < 0.001). Overall in-hospital mortality rate was 9%, dropping from 21% in group A to 7% in group E (P < 0.001). Overall rates of re-exploration for bleeding (11%, P = 0.308) and postoperative dialysis (11%, P = 0.066) remained high across the observed time period. Triple valve replacement, redo sternotomy and poor preoperative left ventricular ejection fraction emerged as strong independent predictors of mortality. CONCLUSIONS: Triple-valve surgery remains rare in the UK. Early postoperative outcomes for triple valve surgery have improved over time. Redo sternotomy is a significant predictor of mortality. Attempts should be made to repair the mitral and/or tricuspid valves where technically possible.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Al-Zubaidi FI, Hussein N, Smith H, et al. 20 Years of triple-valve surgery in the UK: demographic and outcome trends. Eur J Cardiothorac Surg. 2024. PMID: 38984815. doi:10.1093/ejcts/ezae268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。